RedHill Biopharma (RDHL) Return on Sales Growth (5y) (2017 - 2023)
RedHill Biopharma (RDHL) Return on Sales Growth (5y) (2017 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | RedHill Biopharma | 2.05 Bn | 2.05 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 29.00 |
| Mar 31, 2023 | -6.00 |
| Dec 31, 2022 | -15.00 |
| Sep 30, 2022 | -9.00 |
| Jun 30, 2022 | -33.00 |
| Mar 31, 2022 | 2,323.00 |
| Dec 31, 2021 | -103.00 |
| Dec 31, 2020 | -99.00 |
| Jun 30, 2020 | -5,184.00 |
| Dec 31, 2019 | -3,975.00 |
| Sep 30, 2019 | 6.00 |
| Jun 30, 2019 | 9.00 |
| Mar 31, 2019 | -482,079.00 |
| Dec 31, 2018 | -3,511.00 |
| Sep 30, 2018 | 902.00 |
| Jun 30, 2018 | 630.00 |
| Dec 31, 2017 | 203.00 |
| Sep 30, 2017 | 598.00 |
| Jun 30, 2017 | -339.00 |